PUBLISHER: TechNavio | PRODUCT CODE: 2031022
PUBLISHER: TechNavio | PRODUCT CODE: 2031022
Global Ai-Driven Drug Safety And Pharmacovigilance Platforms Market 2026-2030
The global ai-driven drug safety and pharmacovigilance platforms market is forecasted to grow by USD 3103.6 mn during 2025-2030, accelerating at a CAGR of 19.9% during the forecast period. The report on the global ai-driven drug safety and pharmacovigilance platforms market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing volume and complexity of adverse event data, stringent global regulatory requirements for drug safety, imperative for operational efficiency and cost reduction.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 18.7% |
| CAGR | 19.9% |
| Incremental Value | $3103.6 mn |
Technavio's global ai-driven drug safety and pharmacovigilance platforms market is segmented as below:
By Deployment
- Cloud-based platforms
- On-premises solutions
- Hybrid deployment models
By End-User
- Pharma and biotech companies
- Contract research organizations
- Regulatory authorities
- Healthcare providers
By Application
- Adverse event detection
- Risk management
- Literature screening
- Regulatory compliance
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- APAC
- China
- India
- Japan
- Australia
- South Korea
- Indonesia
- Middle East and Africa
- UAE
- South Africa
- Turkey
- South America
- Brazil
- Argentina
- Colombia
- Rest of World (ROW)
This study identifies the integration of generative artificial intelligence for narrative generation as one of the prime reasons driving the global ai-driven drug safety and pharmacovigilance platforms market growth during the next few years. Also, transition toward proactive and real-world evidence monitoring and emergence of cloud-native and modular saas platforms will lead to sizable demand in the market.
The report on the global ai-driven drug safety and pharmacovigilance platforms market covers the following areas:
- Global ai-driven drug safety and pharmacovigilance platforms market sizing
- Global ai-driven drug safety and pharmacovigilance platforms market forecast
- Global ai-driven drug safety and pharmacovigilance platforms market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global ai-driven drug safety and pharmacovigilance platforms market vendors that include Accenture Plc, Anju Software Inc., ArisGlobal LLC, Certara Inc., Clarivate PLC, ClinChoice, Cognizant Technology Solution, Ennov SAS, EXTEDO GmbH, Genpact Ltd., HCL Technologies Ltd., Infosys Ltd., IQVIA Holdings Inc., Medidata Solutions Inc, Navitas Life Sciences, Oracle Corp., Saama Technologies Inc., Sorcero Inc., Tata Consultancy Services, Veeva Systems Inc., WCG Clinical Inc., Wipro Ltd.. Also, the global ai-driven drug safety and pharmacovigilance platforms market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Deployment
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global AI-Driven Drug Safety And Pharmacovigilance Platforms Market 2020 - 2024
- Historic Market Size - Data Table on Global AI-Driven Drug Safety And Pharmacovigilance Platforms Market 2020 - 2024 ($ million)
- 5.2 Deployment segment analysis 2020 - 2024
- Historic Market Size - Deployment Segment 2020 - 2024 ($ million)
- 5.3 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- 5.4 Application segment analysis 2020 - 2024
- Historic Market Size - Application Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of geopolitical conflicts on global AI-driven drug safety and pharmacovigilance platforms market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Deployment
- 8.1 Market segments
- 8.2 Comparison by Deployment
- 8.3 Cloud-based platforms - Market size and forecast 2025-2030
- 8.4 On-premises solutions - Market size and forecast 2025-2030
- 8.5 Hybrid deployment models - Market size and forecast 2025-2030
- 8.6 Market opportunity by Deployment
- Market opportunity by Deployment ($ million)
9 Market Segmentation by End-user
- 9.1 Market segments
- 9.2 Comparison by End-user
- 9.3 Pharma and biotech companies - Market size and forecast 2025-2030
- 9.4 Contract research organizations - Market size and forecast 2025-2030
- 9.5 Regulatory authorities - Market size and forecast 2025-2030
- 9.6 Healthcare providers - Market size and forecast 2025-2030
- 9.7 Market opportunity by End-user
- Market opportunity by End-user ($ million)
10 Market Segmentation by Application
- 10.1 Market segments
- 10.2 Comparison by Application
- 10.3 Adverse event detection - Market size and forecast 2025-2030
- 10.4 Risk management - Market size and forecast 2025-2030
- 10.5 Literature screening - Market size and forecast 2025-2030
- 10.6 Regulatory compliance - Market size and forecast 2025-2030
- 10.7 Market opportunity by Application
- Market opportunity by Application ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.5 APAC - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 India - Market size and forecast 2025-2030
- 12.5.3 Japan - Market size and forecast 2025-2030
- 12.5.4 Australia - Market size and forecast 2025-2030
- 12.5.5 South Korea - Market size and forecast 2025-2030
- 12.5.6 Indonesia - Market size and forecast 2025-2030
- 12.6 Middle East and Africa - Market size and forecast 2025-2030
- 12.6.1 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.2 UAE - Market size and forecast 2025-2030
- 12.6.3 Israel - Market size and forecast 2025-2030
- 12.6.4 South Africa - Market size and forecast 2025-2030
- 12.6.5 Turkey - Market size and forecast 2025-2030
- 12.7 South America - Market size and forecast 2025-2030
- 12.7.1 Brazil - Market size and forecast 2025-2030
- 12.7.2 Argentina - Market size and forecast 2025-2030
- 12.7.3 Colombia - Market size and forecast 2025-2030
- 12.8 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Increasing volume and complexity of adverse event data
- Stringent global regulatory requirements for drug safety
- Imperative for operational efficiency and cost reduction
- 13.2 Market challenges
- Algorithmic opacity and interpretability barrier
- Interoperability and integration with legacy systems
- Shortage of specialized technical and domain expertise
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Integration of generative artificial intelligence for narrative generation
- Transition toward proactive and real-world evidence monitoring
- Emergence of cloud-native and modular SaaS platforms
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Accenture Plc
- Accenture Plc - Overview
- Accenture Plc - Business segments
- Accenture Plc - Key news
- Accenture Plc - Key offerings
- Accenture Plc - Segment focus
- SWOT
- 15.5 ArisGlobal LLC
- ArisGlobal LLC - Overview
- ArisGlobal LLC - Product / Service
- ArisGlobal LLC - Key offerings
- SWOT
- 15.6 Certara Inc.
- Certara Inc. - Overview
- Certara Inc. - Business segments
- Certara Inc. - Key offerings
- Certara Inc. - Segment focus
- SWOT
- 15.7 Cognizant Technology Solution
- Cognizant Technology Solution - Overview
- Cognizant Technology Solution - Business segments
- Cognizant Technology Solution - Key news
- Cognizant Technology Solution - Key offerings
- Cognizant Technology Solution - Segment focus
- SWOT
- 15.8 Ennov SAS
- Ennov SAS - Overview
- Ennov SAS - Product / Service
- Ennov SAS - Key offerings
- SWOT
- 15.9 EXTEDO GmbH
- EXTEDO GmbH - Overview
- EXTEDO GmbH - Product / Service
- EXTEDO GmbH - Key offerings
- SWOT
- 15.10 Genpact Ltd.
- Genpact Ltd. - Overview
- Genpact Ltd. - Business segments
- Genpact Ltd. - Key news
- Genpact Ltd. - Key offerings
- Genpact Ltd. - Segment focus
- SWOT
- 15.11 HCL Technologies Ltd.
- HCL Technologies Ltd. - Overview
- HCL Technologies Ltd. - Business segments
- HCL Technologies Ltd. - Key offerings
- HCL Technologies Ltd. - Segment focus
- SWOT
- 15.12 Infosys Ltd.
- Infosys Ltd. - Overview
- Infosys Ltd. - Business segments
- Infosys Ltd. - Key news
- Infosys Ltd. - Key offerings
- Infosys Ltd. - Segment focus
- SWOT
- 15.13 IQVIA Holdings Inc.
- IQVIA Holdings Inc. - Overview
- IQVIA Holdings Inc. - Business segments
- IQVIA Holdings Inc. - Key offerings
- IQVIA Holdings Inc. - Segment focus
- SWOT
- 15.14 Medidata Solutions Inc
- Medidata Solutions Inc - Overview
- Medidata Solutions Inc - Product / Service
- Medidata Solutions Inc - Key offerings
- SWOT
- 15.15 Oracle Corp.
- Oracle Corp. - Overview
- Oracle Corp. - Business segments
- Oracle Corp. - Key news
- Oracle Corp. - Key offerings
- Oracle Corp. - Segment focus
- SWOT
- 15.16 Sorcero Inc.
- Sorcero Inc. - Overview
- Sorcero Inc. - Product / Service
- Sorcero Inc. - Key offerings
- SWOT
- 15.17 Tata Consultancy Services
- Tata Consultancy Services - Overview
- Tata Consultancy Services - Business segments
- Tata Consultancy Services - Key offerings
- Tata Consultancy Services - Segment focus
- SWOT
- 15.18 Wipro Ltd.
- Wipro Ltd. - Overview
- Wipro Ltd. - Business segments
- Wipro Ltd. - Key news
- Wipro Ltd. - Key offerings
- Wipro Ltd. - Segment focus
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
